Tag:
Prograf
Latest Headlines
Latest Headlines
Judge: No 1st Amendment shield for Astellas' Prograf petition
Japan's Astellas Pharma has to fight antitrust claims related to its transplant drug Prograf. The drugmaker failed to persuade a U.S. judge to dismiss consumer allegations it petitioned the FDA about
LifeCycle shares soar after low-dose organ rejection drug edges Prograf in Ph3
In a head-to-head study with a market leading treatment designed to prevent kidney transplant rejection, Denmark's LifeCycle Pharma says that its once-daily experimental drug edged out Astellas's
Court rejects Astellas bid for FDA injunction
Nice try , Astellas Pharma. The Japanese drugmaker sued the FDA to keep generic copies of its Prograf transplant drug off the market. But the court was less than sympathetic: It rejected Astellas'
Astellas loses bid to stave off copycat Prograf
It's a pitched battle over Prograf. Fast-moving, too: FDA rejected Astellas Pharma's petition for tougher-than-normal approval standards for copycat forms of its transplant drug. Novartis got the FDA
